| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.93▲ | 5.93▲ | 5.95▲ | 6.11▼ | 7.78▼ |
| MA10 | 6.00▲ | 5.99▲ | 6.14▼ | 6.36▼ | 9.10▼ |
| MA20 | 6.30▼ | 6.26▼ | 6.16▼ | 7.90▼ | 10.27▼ |
| MA50 | 6.60▼ | 6.54▼ | 7.29▼ | 9.57▼ | 10.04▼ |
| MA100 | 6.91▼ | 8.27▼ | 8.89▼ | 10.44▼ | 12.44▼ |
| MA200 | 8.70▼ | 9.74▼ | 10.46▼ | 9.86▼ | 18.19▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.024▼ | 0.002▲ | 0.057▲ | -0.113▼ | -0.604▼ |
| RSI | 44.424▼ | 45.736▼ | 44.476▼ | 33.049▼ | 39.018▼ |
| STOCH | 50.944 | 41.887 | 24.275 | 20.147 | 18.318▼ |
| WILL %R | -75.978▼ | -75.978▼ | -75.978▼ | -80.540▼ | -89.907▼ |
| CCI | -41.434 | -43.098 | -48.439 | -79.343 | -161.752▼ |
|
Tuesday, April 22, 2025 06:33 AM
Additionally, investors digested news that Exicure Inc. (NASDAQ:XCUR), through its subsidiary, GPCR Therapeutics USA, was nearing completion of the phase 2 study of GPC-100 in Multiple Myeloma.
|
|
Tuesday, April 22, 2025 02:21 AM
We recently compiled a list of the 10 Micro-, Small-Cap Companies Lead Monday’s Charge. In this article, we are going to take a look at where Exicure Inc. (NASDAQ:XCUR) stands against the other ...
|
|
Tuesday, April 22, 2025 02:21 AM
Additionally, investors digested news that Exicure Inc. (NASDAQ:XCUR), through its subsidiary, GPCR Therapeutics USA, was nearing completion of the phase 2 study of GPC-100 in Multiple Myeloma.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/07/25 | 5.51 | 6.30 | 5.0451 | 5.96 | 84,577 |
| 01/07/25 | 6.22 | 6.75 | 5.62 | 6.10 | 196,400 |
| 30/06/25 | 6.43 | 8.36 | 6.01 | 7.04 | 4,239,306 |
| 27/06/25 | 5.90 | 5.90 | 5.51 | 5.89 | 16,400 |
| 26/06/25 | 5.90 | 6.41 | 5.50 | 5.545 | 10,300 |
| 25/06/25 | 5.42 | 5.817 | 5.42 | 5.75 | 2,800 |
| 24/06/25 | 6.30 | 6.384 | 5.55 | 5.72 | 14,400 |
| 23/06/25 | 7.39 | 7.43 | 6.50 | 6.50 | 22,900 |
| 20/06/25 | 7.74 | 8.28 | 7.47 | 7.47 | 5,500 |
| 18/06/25 | 8.17 | 8.17 | 7.53 | 7.62 | 9,677 |
|
|
||||
|
|
||||
|
|